Glycoside therapy in coronary disease
Dietmann, K.
Wiener Medizinische Wochenschrift 127(20): 627-630
1977
ISSN/ISBN: 0043-5341 PMID: 144371 Document Number: 113543
Document emailed within 1 workday
Related Documents
Schwarzfischer, V.P. 1976: Serum glycoside level in old age. Problems of course control in glycoside therapy Fortschritte der Medizin 94(14): 841-846Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Kirmizibekmez, H.; Taşdemir, D.; Ersöz, T.; Ireland, C.M.; Caliş, I. 2002: A new pregnane glycoside and a furostanol glycoside from Digitalis cariensis Die Pharmazie 57(10): 716-720
Kubicek, F. 1983: Alternatives to glycoside therapy? Wiener Klinische Wochenschrift 95(17): 607-611
Rösner, K. 1979: Improvement of cardiac glycoside therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(12): 337-338
Jordan, D.; Junge, N.; Schröder, K.; Schulz, K.; Spangenberg, K.; Wüstenberg, P.W. 1975: Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication) Zeitschrift für Arztliche Fortbildung 69(19): 1017-1021
Bock, K. 1985: Glycoside therapy--indications and dosage in childhood Kinderarztliche Praxis 53(8): 371-373
Bodem, G.; Ochs, H.R.; Meyer, R.; Baur, M.P. 1979: Prospective evaluation of glycoside therapy of patients on admission to hospital Zeitschrift für Kardiologie 68(1): 41-49
Kuhlmann, J.; Rietbrock, N. 1976: Glycoside-plasma level under maintenance therapy--dispersion of the concentrations and its causes Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1704-1709
Tilsner, V. 1970: Electrolyte therapy for prevention and treatment of glycoside side effects Münchener Medizinische Wochenschrift 112(7): 291-297
Leschke, M.; Mecklenbeck, W.; Strauer, B.E. 1992: Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms Medizinische Klinik 87(7): 385-389
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Trenkwalder, P.; Lydtin, H. 1992: Therapy of coronary disease Deutsche Medizinische Wochenschrift 117(1): 37-38
Stauch, M. 1979: The value of drug therapy in coronary disease ZFA. Zeitschrift für Allgemeinmedizin 55(28): 1577
Hofmeier, G.; Volkmer, I. 1974: Surgical therapy of coronary disease Die Medizinische Welt 25(12): 518-520
Niederberger, M. 1976: Therapy of coronary heart disease Wiener Medizinische Wochenschrift 126(32-35): 469-473
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Christandl, B. 1981: Therapy of coronary disease with the beta-blocker betapressin Fortschritte der Medizin 99(36): 1473-1476
Leschke, M.; Motz, W.; Strauer, B.E. 1986: Hemorheologic therapy applications in coronary heart disease Wiener Medizinische Wochenschrift 136(Special Issue): 17-24